As LiCl is an inhibitor of GSK3β, a key regulator of cardiac hypertrophy, it was important to assess its activity through Western blot measurement of total and Ser9 phosphorylation (inhibited) state (Hamstra, Whitley, et al., 2020; Michael et al., 2004). This evidence concerns the gene GSK3B and cardiac hypertrophy.